Tredje Ap Fonden Viatris Inc Transaction History

Tredje Ap Fonden

$10.3 Billion
Q1 2025

A detailed history of Tredje Ap Fonden transactions in Viatris Inc stock. As of the latest transaction made, Tredje Ap Fonden holds 315,089 shares of VTRS stock, worth $2.79 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

315,089

Previous 93,485 237.05%

Holding current value

$2.79 Million

Previous $1.16 Million 135.94%

% of portfolio

0.03%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$8.68 - $12.42 $1.92 Million - $2.75 Million	221,604 Added 237.05%	315,089 $2.74 Million
Q4 2024 Feb 10, 2025	SELL	$11.32 - $13.37 $1.06 Million - $1.25 Million	-93,485 Reduced 50.0%	93,485 $1.16 Million
Q2 2024 Aug 12, 2024	SELL	$10.05 - $12.02 $29,607 - $35,410	-2,946 Reduced 1.55%	186,970 $1.99 Million
Q4 2023 Feb 12, 2024	SELL	$8.77 - $10.85 $70,107 - $86,734	-7,994 Reduced 4.04%	189,916 $2.06 Million
Q3 2023 Nov 09, 2023	SELL	$9.59 - $11.35 $173,646 - $205,514	-18,107 Reduced 8.38%	197,910 $1.95 Million
Q2 2023 Aug 11, 2023	SELL	$9.02 - $10.29 $370,983 - $423,217	-41,129 Reduced 15.99%	216,017 $2.16 Million
Q1 2023 May 10, 2023	SELL	$9.2 - $12.26 $828,202 - $1.1 Million	-90,022 Reduced 25.93%	257,146 $2.47 Million
Q4 2022 Feb 10, 2023	BUY	$8.72 - $11.56 $135,055 - $179,041	15,488 Added 4.67%	347,168 $3.86 Million
Q3 2022 Nov 10, 2022	BUY	$8.48 - $11.13 $1.68 Million - $2.21 Million	198,226 Added 148.54%	331,680 $2.83 Million
Q4 2021 Feb 10, 2022	BUY	$12.09 - $14.68 $869,609 - $1.06 Million	71,928 Added 116.91%	133,454 $1.81 Million
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $879,821 - $1.15 Million	61,526 New	61,526 $1.15 Million

Others Institutions Holding VTRS

# of Institutions

1,136

Shares Held

953M

Call Options Held

4.15M

Put Options Held

2.65M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $10.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.

Account